Of note, previous studies with breast cancer and ovarian cancer cells correlated CHKα expression with increased cellular invasiveness, migration, and proliferation [23, 49], indicating the importance of CHKα as a regulator of the mesenchymal phenotype in other tumors than GBM. The gene discussed is CHKA; the disease is glioblastoma.